MONDAY, Sept. 26, 2022 (HealthDay News) There was a 23.5 percent national decrease in substance use disorder (SUD) treatment admissions during the beginning of the COVID-19 pandemic, according to
Substance Use Disorder Treatment Admissions Down During Pandemic psu.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from psu.edu Daily Mail and Mail on Sunday newspapers.
Admissions to drug treatment programs declined by nearly one-quarter during the first year of the COVID-19 pandemic, with the cuts steepest among people of color, according to a new RAND Corporation study. It touts itself as the first national analysis to establish declines in the number of treatment admissions during the COVID-19 pandemic, and provides one possible reason for
Share
Approximately 6.5 million people are under correctional supervision in the United States on any given day. Justice-involved individuals (people currently or recently in prison or jail, on probation or parole, or arrested) experience higher rates of substance use disorders than the general population. In fact, among people with opioid use disorder (OUD), more than half have reported contact with the criminal justice system.
Numerous clinical studies have shown that medications for OUD specifically, methadone or buprenorphine lead to superior outcomes for retention in treatment, reduced illicit opioid use, and decreased opioid-related overdose rates and serious acute care compared with treatments that rely on psychosocial interventions alone. However, due to a number of barriers, including access to health insurance, access to medications for OUD for those on parole, formerly incarcerated, or recently arrested remain significantly lower than the general population.
Date Time
Medication Access for Opioid Use Disorder Lower Among Those Involved with Criminal Justice System
PHILADELPHIA Approximately 6.5 million people are under correctional supervision in the United States on any given day. Justice-involved individuals (people currently or recently in prison or jail, on probation or parole, or arrested) experience higher rates of substance use disorders than the general population. In fact, among people with opioid use disorder (OUD), more than half have reported contact with the criminal justice system.
Numerous clinical studies have shown that medications for OUD specifically, methadone or buprenorphine lead to superior outcomes for retention in treatment, reduced illicit opioid use, and decreased opioid-related overdose rates and serious acute care compared with treatments that rely on psychosocial interventions alone. However, due to a number of barriers, including access to health insurance, access to medications for OUD for those o